Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.55 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.53 |
| ▸ | TNKS | O95271 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL901445 | 0.91 | PTGS2 (0.64) | PTGS2AKR1B1TNKS2ALOX5LMNA | |
| Methane SCHEMBL29229953 | 0.89 | PTGS2 (0.61) | PTGS2AKR1B1TNKS2ALOX5LMNA | |
| SCHEMBL16502336 | 0.86 | PTGS2 (0.53) | PTGS2AKR1B1TNKS2TNKSTSHR | |
| SCHEMBL25383363 | 0.85 | TNKS2 (0.65) | PTGS2AKR1B1TNKS2TNKSALOX5 | |
| SCHEMBL8372028 | 0.83 | PTGS2 (0.73) | PTGS2CYP3A4TUBB4ATUBBTUBA3C | |
| SCHEMBL3041350 | 0.83 | AKR1B1 (0.61) | AKR1B1TNKS2TNKSTSHRTAAR1 | |
| SCHEMBL12121960 | 0.83 | PTGS2 (0.55) | PTGS2AKR1B1TNKS2TNKSALOX5 | |
| SCHEMBL10285344 | 0.83 | AKR1B1 (0.55) | PTGS2AKR1B1TNKS2TNKSTSHR | |
| SCHEMBL17263518 | 0.83 | AKR1B1 (0.76) | AKR1B1TNKS2TNKSTSHRTAAR1 | |
| SCHEMBL12766044 | 0.82 | PTGS2 (0.60) | PTGS2AKR1B1TNKS2MAPK1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3571180-B1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | UNIV LEUVEN KATH (BE) | 2024-12-18 | — | — | EP | disclosed |
| US-20210070684-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2021-03-11 | — | — | US | disclosed |
| EP-3571180-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | Katholieke Universiteit Leuven (BE) | 2019-11-27 | — | — | EP | disclosed |
| WO-2018134427-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2018-07-26 | — | — | WO | disclosed |
| WO-2015133867-A1 | OFFSET PRINTING COMPOSITION, PRINTING METHOD USING SAME, AND PATTERN COMPRISING OFFSET PRINTING COMPOSITION | 주식회사 엘지화학 | 2015-09-11 | — | — | WO | disclosed |
| US-8476414-B2 | Substrates and internal standards for mass spectrometry detection | PERKINELMER HEALTH SCIENCES, INC. (US) | 2013-07-02 | — | — | US | disclosed |
| US-20120077871-A1 | 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof | TAPESTRY PHARMACEUTICALS, INC. (US) | 2012-03-29 | — | — | US | disclosed |
| US-20110275708-A1 | POLYCYCLIC COMPOUNDS AND METHODS RELATED THERETO | CORNELL UNIVERSITY (US) | 2011-11-10 | — | — | US | disclosed |
| US-20110071142-A1 | IDENTIFICATION AND USE OF SMALL MOLECULES TO MODULATE TRANSCRIPTION FACTOR FUNCTION AND TO TREAT TRANSCRIPTION FACTOR ASSOCIATED DISEASES | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077871-A1 | 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof | TECR, ADCY9, AKR1C3 | PTGS2 2150/4885AKR1B1 39/4885TNKS2 2873/4885 |
| US-20210070684-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | MMS19, PCBP1, PBRM1 | PTGS2 2870/4885AKR1B1 658/4885TNKS2 2737/4885 |
| US-20110275708-A1 | POLYCYCLIC COMPOUNDS AND METHODS RELATED THERETO | PKD1, THPO, CCNO | PTGS2 141/4885AKR1B1 460/4885TNKS2 1445/4885 |
| US-20110071142-A1 | IDENTIFICATION AND USE OF SMALL MOLECULES TO MODULATE TRANSCRIPTION FACTOR FUNCTION AND TO TREAT TRANSCRIPTION FACTOR ASSOCIATED DISEASES | CREBBP, TEAD1, SREBF1 | PTGS2 946/4885AKR1B1 1900/4885TNKS2 1685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.